TamaraPorterMillerMDMSCE
Pediatric Hematology & Oncology • Atlanta, GAPediatric Hematologic Oncology
Associate Professor, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1750 Haygood Drive
Emory University
Atlanta, GA 30322
Education & Training
The University of PennsylvaniaMSCE, Epidemiology, 2012 - 2015
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2011 - 2014- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2008 - 2011
Yale School of MedicineClass of 2008
Certifications & Licensure
GA State Medical License 2017 - 2025
PA State Medical License 2008 - 2018- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation Start of enrollment: 2020 Sep 18
Roles: Principal Investigator
- Pilot Study to Enable Electronic Laboratory Data Transfer From Participating Institutions to MediData/RAVE Start of enrollment: 2021 Aug 28
Publications & Presentations
PubMed
- 14 citationsRates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from ...Tamara P Miller, Kelly D Getz, Yimei Li, Biniyam G Demissei, Peter C Adamson
The Lancet. Haematology. 2022-09-01 - 7 citationsQuantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia.Zachary West, Sharon M. Castellino, Caitlin Monroe, Amanda S. Thomas, Courtney McCracken
Leukemia & Lymphoma. 2021-03-21 - 2 citationsAn Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia.Irfan Al-Hussaini, Brandon White, Armon Varmeziar, Nidhi Mehra, Milagro Sanchez
Journal of Clinical Medicine. 2024-03-20
Journal Articles
- Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P. Miller, Yimei Li, Marko Kavcic, Andrea B. Troxel, Yuan-Shun V. Huang, Lillian Sung, Todd A. Alonzo, Robert Gerbing, Matt Hall, Marla H. Daves, Terzah M. Hor..., Journal of Clinical Oncology, 2/16/2016
Abstracts/Posters
- Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Pa...Tamara P. Miller, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Delays in Therapy Do Not Impact Survival in Childhood Acute Lymphoblastic Leukemia: A Report from the Learn ConsortiumTamara P. Miller, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019
- Rates of Laboratory Adverse Events By Chemotherapy Course for Pediatric Acute Leukemia Patients within the Leukemia Electronic Abstraction of Records Network (LEARN)Miller TP*, Getz KD, Demissei B, Rabin KR, Daves M, Lupo PJ, Scheurer ME, Burrows E, Fisher BT, Grundmeier RW, Lee J, Wilkes JJ, Winestone LE, Gramatges MMJ, Aplenc R, 61st American Society of Hematology Annual Meeting, 12/7/2019
Press Mentions
Reporting Side Effects: Methods to Enhance Quality of LifeAugust 10th, 2017- Parents and Caregivers Report a Reduction in Anxiety and Distress in Young Cancer Patients Using the My Special Aflac DuckApril 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
